Analyst Ratings For Envision Healthcare (NYSE:EVHC)
Today, Robert W. Baird reiterated its Outperform rating on Envision Healthcare (NYSE:EVHC) with a price target of $50.00.
Some recent analyst ratings include
- 3/7/2018-Robert W. Baird Reiterated Rating of Outperform.
- 3/1/2018-Royal Bank of Canada Reiterated Rating of Buy.
- 2/28/2018-Canaccord Genuity Reiterated Rating of Buy .
- On 7/3/2017 Robert Jon Coward, Insider, sold 1,500 with an average share price of $62.69 per share and the total transaction amounting to $94,035.00.
- On 6/22/2017 Robert Jon Coward, Insider, sold 1,500 with an average share price of $60.00 per share and the total transaction amounting to $90,000.00.
- On 5/3/2017 Robert Jon Coward, Insider, sold 1,500 with an average share price of $60.53 per share and the total transaction amounting to $90,795.00.
- On 4/3/2017 Robert Jon Coward, Insider, sold 1,500 with an average share price of $61.34 per share and the total transaction amounting to $92,010.00.
- On 3/10/2017 John Thomas Gawaluck, Director, bought 1,500 with an average share price of $66.65 per share and the total transaction amounting to $99,975.00.
- On 3/1/2017 Robert Jon Coward, Insider, sold 1,500 with an average share price of $65.00 per share and the total transaction amounting to $97,500.00.
- On 10/5/2015 Leonard M Riggs Jr, Director, sold 4,000 with an average share price of $36.24 per share and the total transaction amounting to $144,960.00.
Recent Trading Activity for Envision Healthcare (NYSE:EVHC)
Shares of Envision Healthcare closed the previous trading session at 42.24 up +0.52 1.23% with shares trading hands.